Showing 5801-5810 of 21469 results for "".
- Chronic Hydroxyurea Therapy in Pediatric Sickle Cell Anemia: Efficacy, Mechanisms, and Safetyhttps://reachmd.com/news/chronic-hydroxyurea-therapy-in-pediatric-sickle-cell-anemia-efficacy-mechanisms-and-safety/2484749/In children with sickle cell anemia, chronic hydroxyurea reduces vaso-occlusive events and improves systemic outcomes. Trial-level reductions
- Ultrasound Helps Clinicians Target Filler Complications with Greater Precisionhttps://reachmd.com/news/ultrasound-helps-clinicians-target-filler-complications-with-greater-precision/2484765/Ultrasound imaging may play a critical role in identifying and treating serious vascular complications associated with hyaluronic acid filler injections, according to new research presented at the 2025 Radiological Society of North America (RSNA) annual meeting. Researchers led by Rosa Mar
- Evolving Strategies in Anesthetic Management of Femur Fractureshttps://reachmd.com/news/anesthetic-management-femur-fractures/2484723/A randomized controlled trial in patients with proximal femur fractures directly compared peripheral nerve blocks to spinal anesthesia and found markedly lower intraoperative
- Phase 3 Outcomes Highlight Rocatinlimab’s Potential in Treating Moderate-to-Severe Eczemahttps://reachmd.com/news/phase-3-outcomes-highlight-rocatinlimabs-potential-in-treating-moderate-to-severe-eczema/2484711/Rocatinlimab produced clinically meaningful improvement in moderate-to-severe atopic dermatitis in two phase 3 trials,
- MEL-SELF Analysis: Comparable Outcomes Between Affordable and Premium Dermatoscopeshttps://reachmd.com/news/analysis-shows-comparable-outcomes-between-affordable-and-premium-dermatoscopes/2484733/A new randomized study embedded within the MEL-SELF trial suggests both low-cost and high-cost dermatoscopes enabled patients with a history of early-stage melanoma to effectively capture images for remote dermatologic assessment.
- Diagnostic Challenges and Demographic Disparities in Heart Failure Carehttps://reachmd.com/news/diagnostic-demographic-challenges-heart-failure/2484718/A retrospective cohort study of over 400,000 patients reports substantial underuse of guideline-recommended heart failure investigations and marked dem
- Genetic Discovery Fuels New Avenues in CKD Therapyhttps://reachmd.com/news/genetic-discovery-ckd-therapy/2484727/A University of Missouri preclinical analysis links multiple CKD-associated genes to fibrosis and inflammatory pathways, high
- Clascoterone 5% Solution Achieves Hair Regrowth in Large AGA Studyhttps://reachmd.com/news/clascoterone-5-solution-acheives-hair-regrowth-in-large-aga-study/2484730/Cosmo Pharmaceuticals N.V. has reported phase 3 results from its two pivotal trials—Scalp 1 (NCT05910450) and Scalp 2 (NCT05914805)—evaluating clascoterone 5% topical solution for male androgenetic alopecia (AGA). According t
- Link Between Sleep Apnea Treatment and Reduced Parkinson’s Disease Riskhttps://reachmd.com/news/sleep-apnea-treatment-parkinsons-risk/2484684/Treating obstructive sleep apnea with continuous positive airway pressure (CPAP) was associated with a substantially lower incidence of Parkinson’s disease in a large U.S. veterans
- Breakthrough in HIV: Combination Therapy and Long-term Controlhttps://reachmd.com/news/hiv-combination-therapy-long-term-control/2484687/A UCSF study reports that a combination immunotherapy approach enabled 7 of 10 participants to maintain low-level HIV viremia for several months after stopping antiretroviral therapy,